A critical vulnerability dubbed Java4Shell in OpenJDK, the open-source implementation of Java, can allow unauthenticated ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Anthropic claims to be near something along the lines of recursive self-improvement, or RSI, according to the latest revision of its S-1/A filing, published Monday. The new warning in the “Risk ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
AI's share of AI-model research and development at Anthropic, by month Note: As of August, 0% of AI R+D is fully autonomous. Parts may not add to 100% due to rounding. Note: As of August, 0% of AI R+D ...
You're currently following this author! Click to unsubscribe from email alerts. Google's AI models may be helping to build their successors, but CEO Sundar Pichai says the moment of fully ...
Recent insider activity at Recursion Pharmaceuticals consisted of 3 Tax Payment transactions by 3 insiders, totaling $437,905.65 across 111,490 shares on November 16, 2026. Average transaction value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results